Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | RARB | P10826 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10578573 | 0.98 | DGKA (0.53) | DGKADNM1TSHRNAAACYP3A4 | |
| SCHEMBL29797095 | 0.93 | DGKA (0.61) | DGKADNM1TSHRNAAAHTR2C | |
| SCHEMBL31121693 | 0.91 | DGKA (0.58) | DGKADNM1TSHRNAAACYP3A4 | |
| SCHEMBL18179722 | 0.89 | DGKA (0.48) | DGKADNM1TSHRNAAAHTR2C | |
| SCHEMBL157557 | 0.88 | DGKA (0.57) | DGKADNM1TSHRNAAAHTR2C | |
| SCHEMBL1302517 | 0.88 | DGKA (0.63) | DGKADNM1TSHRNAAACYP3A4 | |
| SCHEMBL17375071 | 0.88 | DGKA (0.63) | DGKADNM1TSHRNAAACYP3A4 | |
| SCHEMBL16837163 | 0.88 | DGKA (0.63) | DGKADNM1TSHRNAAACYP3A4 | |
| SCHEMBL23349392 | 0.86 | DGKA (0.41) | DGKADNM1TSHRHTR2CEPHX2 | |
| SCHEMBL10579418 | 0.86 | DGKA (0.55) | DGKADNM1TSHRNAAAHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218799-A1 | BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT | AQUARIAN CREDIT FUNDING LLC | 2023-07-13 | — | — | US | disclosed |
| US-20180050129-A1 | BIOCOMPATIBLE HYDROGEL POLYMER MATRIX FOR DELIVERY OF CELLS | THERAGENICS CORPORATION | 2018-02-22 | — | — | US | disclosed |
| US-20130116341-A1 | IN-VIVO GELLING PHARMACEUTICAL PRE-FORMULATION | MEDICUS BIOSCIENCES, LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-4873351-A | REACTING ANTIMONY TRIOXIDE WITH ORGANIC MERCAPTAN IN THE PRESENCE OF A LOWER ALIPHATIC CARBOXYLIC ACID | SAKAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218799-A1 | BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT | ALDH1A2, RB1, UACA | DGKA 3244/4885DNM1 2026/4885TSHR 1883/4885 |
| US-20180050129-A1 | BIOCOMPATIBLE HYDROGEL POLYMER MATRIX FOR DELIVERY OF CELLS | CD44, MMP1, ILK | DGKA 3848/4885DNM1 1752/4885TSHR 4136/4885 |
| US-20130116341-A1 | IN-VIVO GELLING PHARMACEUTICAL PRE-FORMULATION | FURIN, ARFGAP1, MGST1 | DGKA 2617/4885DNM1 1950/4885TSHR 4254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.